Sunday, June 26, 2022
Home Technology Benchling, which makes cloud-based software to manage biotech R&D, raises a $100M...

Benchling, which makes cloud-based software to manage biotech R&D, raises a $100M Series F at a $6.1B valuation; Benchling was last valued at $4B in April (Michelle F Davis/Bloomberg)



Michelle F Davis / Bloomberg:

Benchling, which makes cloud-based software to manage biotech R&D, raises a $100M Series F at a $6.1B valuation; Benchling was last valued at $4B in April  —  – New investor Franklin Templeton leads round with Altimeter  — Companies using firm’s software include Regeneron, Eli Lilly





Source link

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -

Most Popular

Recent Comments